Williamson
Williamson v. Genentech, Inc.
Opinion
trial_court Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 ANDREW WILLIAMSON, Case No. 19-cv-01840-JSC
8 Plaintiff,
ORDER REMANDING ACTION TO
9 v. STATE COURT FOR LACK OF
SUBJECT MATTER JURISDICTION
10 GENENTECH, INC., et al.,
Defendants. 11
12 13 Andrew Williamson brings this action on behalf of himself and other similarly situated 14 individuals alleging that Genentech Inc.’s sale of prescription drugs in single-dose vials results in 15 waste of medication and violates California’s Unfair Competition Law, California Business and 16 Professions Code § 17200 (the “UCL”). Genentech’s motion to dismiss the complaint based on 17 federal impossibility preemption, or alternatively, based on California’s judicial-abstention 18 doctrine or for failure to state a claim came before the Court for a hearing on November 21, 2019.1 19 (Dkt. No. 30.) At the hearing, the Court noted that before addressing Genentech’s motion, it must 20 ensure that it has Article III standing to hear this action which was removed from the Superior 21 Court for…